SavedAdd your journal

Journals / Fırat Tıp Dergisi / 2018 / Cilt: 23 - Sayı: 0

Surgical Treatment of Obesity

Obezitenin Cerrahi Tedavisi

Haydar ÖCAL
ERHAN AYGEN
Pages
78–87
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Lifelong follow-up is necessary because of nutritional deficiencies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Rapidly increasing rate of obesity may also cause an increase in obesity related comorbidities.
📊
Key Findings & Data:Diet is a very important part in the treatment of obesity; despite it is very hard to accomplish in case of morbid obesity.
💡
Conclusion & Impact:Lifelong follow-up is necessary because of nutritional deficiencies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Rapidly increasing rate of obesity may also cause an increase in obesity related comorbidities. Diet is a very important part in the treatment of obesity; despite it is very hard to accomplish in case of morbid obesity. So, bariatric surgery is carried out as a reliable and effective choice. Bariatric procedu-res are classified as restrictive, malabsorptive or combined according to their mechanism of action. Laparoscopic sleeve gastrectomy has an efficacy close to roux-n-y gastric bypass in terms of weight loss. Bacause of its ease to perform, succesful results and its redo surgery is more comfortable, sleeve gastrectomy technique is incrased in use. Obesity surgery provides weight loss and resolution of comorbid conditions. This has serious socioe-conomic implications. Patient adherence to postsurgical aspects of management is very important for long lasting weight loss. Lifelong follow-up is necessary because of nutritional deficiencies.

Özet

Morbid obezite beraberinde getirdiği yandaş birçok hastalıkla birlikte hızla artmaktadır. Tedavisinde diyetin çok önemli bir yeri vardır, fakat diyetle sonuca ulaşmak çok zordur. Bu nedenle de morbid obezite için cerrahi tedavi uygun ve kalıcı bir seçenek olarak uygulanmaktadır. Obezite cerrahisin-de gıda tüketimini kısıtlayan, emilimi azaltan veya her iki etkiye sahip olan farklı teknikler sınıflandırılmıştır. Son yıllarda laparoskopik sleeve gast-rektomi, roux y gastrik bypass’a benzer kilo verim oranları ile pratikte yerini almıştır. Sleeve gastrektomi; uygulamasının kolay olması, başarılı so-nuçlarının olması ve redo cerrahisinin daha rahat olması nedeniyle kullanımı artmaktadır. Obezite cerrahisi kilo verimini sağlayarak yandaş hastalıkla-rın da yüksek oranda düzelmesini sağlamaktadır. Buna bağlı olarak sosyo-ekonomik yük de azalmaktadır. Hastanın ameliyat sonrası önerileri uygu-laması etkili ve kalıcı kilo verimi için gereklidir. Bu hastalara nutrisyonel eksiklikler için ömür boyu takip de gerekmektedir.

🔖

Cite This Article

ÖCAL, H., AYGEN, E. (2018). Surgical Treatment of Obesity. Fırat Tıp Dergisi, Cilt: 23 - Sayı: 0, 78–87. https://ajindex.com/articles/223553

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sjostrom L, Kindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk fac-tors 10 years after bariatric surgery. N Engl J Med 2004 23; 351: 2683-93. Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab 2008; 93 (11 Suppl 1): S89-96. O’Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepa-tol 2010; 25: 1358-65
  2. Hng KN, Ang YS. Overview of bariatric sur-gery for the physician. Clin Med 2012; 12: 435-40.
  3. Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinol Metab Clin North Am 2008; 37: 943-64.
  4. Karra E, Yousseif A, Batterham RL. Mecha-nisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery. Trends Endocrinol Metab 2010; 21: 337-44.
  5. Beard JH, Bell RL, Duffy AJ. Reproductive considerations and pregnancy after bariatric surgery: current evidence and recommendations. Obes Surg 2008; 18: 1023-7.
  6. Kokkinos P, Moutsatsos G. Obesity and cardio-vascular disease: the role of diet and physical activity. J Cardiopulm Rehabil 2004; 24: 197-203.
  7. Jordan J, Schlaich M, Redon J, et al. European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular out-comes J Hypertens 2011; 29: 189-93. Elangbam CS. Review paper: current strategies in the development of anti-obesity drugs and their safety concerns Vet Pathol 2009; 46: 10-24.
  8. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37. Cannon-Diehl MR. Emerging issues for the postbariatric surgical patient. Crit Care Nurs Q 2010; 33: 361-70.
  9. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases longterm mortality, morbi-dity, and health care use in morbidly obese pati-ents. Ann Surg 2004; 240: 416-23.
  10. Sjöström L, Narbro K, Sjöström CD, et al. Ef-fects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-52.
  11. Ochner CN, Gibson C, Shanik M, Goel V, Ge-liebter A. Changes in neurohormonal gut pepti-des following bariatric surgery. Int J Obes 2011; 35: 153-66.
  12. Clegg AJ, Colquitt J, Sidhu MK, Royle P, Lo-veman E, Walker A. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technology Assess 2002; 6: 1-153.
  13. Birmingham CL, Jones PJ. Clinical nutrition: 5 How much should Canadians eat? Canadian Med Association J 2002; 166: 770. Douketis JD, Feightn